386 related articles for article (PubMed ID: 28479851)
21. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.
Srinutta T; Chewcharat A; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Jaber BL; Susantitaphong P
Medicine (Baltimore); 2019 Nov; 98(44):e17788. PubMed ID: 31689852
[TBL] [Abstract][Full Text] [Related]
23. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.
Li CM; Zhernakova A; Engstrand L; Wijmenga C; Brusselaers N
Aliment Pharmacol Ther; 2020 Feb; 51(4):410-420. PubMed ID: 31909512
[TBL] [Abstract][Full Text] [Related]
24. The Risk of Community-Acquired Enteric Infection in Proton Pump Inhibitor Therapy: Systematic Review and Meta-analysis.
Hafiz RA; Wong C; Paynter S; David M; Peeters G
Ann Pharmacother; 2018 Jul; 52(7):613-622. PubMed ID: 29457492
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
27. Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study.
Svanström H; Lund M; Melbye M; Pasternak B
Drug Saf; 2018 Aug; 41(8):817-826. PubMed ID: 29603109
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies.
Wu X; Zhang D; Yu Y; Lou L; Li X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32406491
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis.
Ma YJ; Cao ZX; Li Y; Feng SY
World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
Ma T; Wu M; Jia S; Yang L
Int J Colorectal Dis; 2020 Dec; 35(12):2157-2169. PubMed ID: 32808072
[TBL] [Abstract][Full Text] [Related]
31. Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis.
Zuo T; Jiang L; Mao S; Liu X; Yin X; Guo L
Int J Cardiol; 2016 Dec; 224():286-294. PubMed ID: 27665399
[TBL] [Abstract][Full Text] [Related]
32. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Park CH; Kim EH; Roh YH; Kim HY; Lee SK
PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
[TBL] [Abstract][Full Text] [Related]
33. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
Shi D; Zhou Z; Dai Y; Pan X; Cao Q
Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
[TBL] [Abstract][Full Text] [Related]
34. The use of anti-ulcer agents and the risk of chronic kidney disease: a meta-analysis.
Sun J; Sun H; Cui M; Sun Z; Li W; Wei J; Zhou S
Int Urol Nephrol; 2018 Oct; 50(10):1835-1843. PubMed ID: 29948864
[TBL] [Abstract][Full Text] [Related]
35. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
36. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
[TBL] [Abstract][Full Text] [Related]
37. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
38. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis.
Li M; Luo Z; Yu S; Tang Z
Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis.
Liu J; Li X; Fan L; Yang J; Wang J; Sun J; Wang Z
Life Sci; 2019 Feb; 218():213-223. PubMed ID: 30605646
[TBL] [Abstract][Full Text] [Related]
40. Risk of acute kidney injury in patients with HIV receiving proton pump inhibitors.
Sutton SS; Magagnoli J; Cummings TH; Hardin JW
J Comp Eff Res; 2019 Jul; 8(10):781-790. PubMed ID: 31167563
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
